ArticleEuropean heart journal open2024
Correction to: Effectiveness of icosapent ethyl on first and total cardiovascular events in patients with metabolic syndrome, but without diabetes: REDUCE-IT MetSyn.
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.